首页 > 市场调查报告书 > 医疗设备

生技设备

细胞计数市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902392

细胞计数市场规模、份额及成长分析（按产品、应用、最终用户及地区划分）－2026-2033年产业预测

Cell Counting Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Application (Research Applications, Medical Applications), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 189 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，细胞计数市场规模将达到 111.8 亿美元，到 2025 年将达到 119.4 亿美元，到 2033 年将达到 202.1 亿美元，预测期（2026-2033 年）的复合年增长率为 6.8%。

细胞计数市场正经历显着成长，这主要得益于细胞生物学、癌症研究和免疫学领域研究的不断深入。推动该市场发展的关键因素包括对个人化医疗日益增长的需求、慢性病盛行率的急剧上升以及细胞计数技术的进步。然而，操作技术复杂性和训练有素的专业人员短缺等挑战可能会阻碍市场发展。儘管存在这些障碍，但由于创新技术的涌现、细胞疗法日益重要以及数位化解决方案的整合，预计该市场仍将持续成长。因此，细胞计数领域将持续发展演进，反映其在各个领域，尤其是在改善医学研究和诊断方面发挥的关键作用。

细胞计数市场驱动因素

细胞计数市场的成长主要得益于技术创新，例如精密可靠的自动化细胞计数仪器、先进的流式细胞仪和高级成像系统的问世。这些发展推动了市场需求的成长，并刺激了市场扩张。现代细胞计数解决方案能够提供快速、准确的结果和全面的分析，从而提高了效率和准确性，这也促进了市场成长。最终，这些技术进步在改善临床诊断和提升研究成果方面发挥关键作用，进一步推动了市场发展，并凸显了高效细胞计数方法在各个应用领域的重要性。

限制细胞计数市场发展的因素

在某些地区，各种细胞计数系统的报销选择有限，这给其经济可行性带来了挑战，并可能阻碍医疗机构和研究人员采用该技术。这种限制会导致对细胞计数系统的需求下降，最终抑制市场扩张。此外，缺乏适当的报销机制会抑制对创新细胞计数技术的投资，使相关人员难以探索或实施这些技术进步。因此，这些财务障碍显着限制了细胞计数解决方案在医疗保健领域的潜在成长和整体应用。

细胞计数市场趋势

细胞计数市场正经历显着的转变，除了传统的细胞计数技术外，人们也开始更加关注细胞功能和活力。研究人员和临床医生日益认识到，评估细胞数量固然重要，但评估细胞的健康状况和活性同样至关重要，这对于再生医学、药物研发和癌症研究等前沿应用至关重要。这一趋势正在推动创新技术的开发，这些技术致力于全面评估细胞行为，最终有助于更深入地了解细胞机制。因此，对能够更深入理解细胞活力和功能的先进工具和调查方法的需求预计将塑造该市场的未来模式。

消耗品
- 培养基、血清和试剂
- 检测试剂盒
- 微孔盘
- 配件
- 其他消耗品
装置
- 光强度
- 单模读卡机
- 多模式阅读器
- 流式细胞仪
- 血液分析仪
- 全自动分析仪
- 半自动血液分析仪
- 细胞计数器
- 自动细胞计数器
- 血球计数器/手动细胞计数器
- 显微镜

按应用分類的细胞计数市场

研究用途
- 癌症研究
- 免疫学研究
- 神经学检查
- 干细胞研究
- 其他研究应用
医疗用途
- 非侵入性产前检测
- 体外受精
- 循环性肿瘤细胞检测
工业应用

按最终用户分類的细胞计数市场

研究所
医院和诊断检查室
製药和生物技术公司以及受託研究机构（CRO）
其他最终用户

按地区分類的细胞计数市场规模

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Danaher Corporation（US）
Thermo Fisher Scientific（US）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
Bio-Rad Laboratories Inc.（US）
Abbott Laboratories（US）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Corning（US）
Tecan（Switzerland）
Boule Diagnostics AB（Sweden）
Olympus Corporation（Japan）
Horiba（Japan）
Sysmex Corporation（Japan）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche AG（Switzerland）
Luminex Corporation（US）
Nexcelom Bioscience LLC（US）
Tip Biosystems（Singapore）
Logos Biosystems, Inc.（South Korea）

简介目录

Product Code: SQMIG35H2305

Cell Counting Market size was valued at USD 11.18 Billion in 2024 and is poised to grow from USD 11.94 Billion in 2025 to USD 20.21 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The cell counting market is witnessing significant growth driven by an increase in research across cell biology, cancer research, and immunology. Key factors propelling this market include the rising demand for personalized medicine, a surge in chronic disease prevalence, and advancements in cell counting technologies. However, challenges such as operational technical complexity and a shortage of trained professionals may hinder progress. Despite these obstacles, the market is anticipated to thrive, fueled by the advent of innovative technologies, the escalating importance of cell-based therapies, and the integration of digital solutions. Consequently, the landscape for cell counting is set for continuous evolution, reflecting its critical role in various fields, particularly in enhancing medical research and diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Counting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Counting Market Segments Analysis

Global Cell Counting Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Application, the market is segmented into Research Applications, Medical Applications, and Industrial Applications. Based on End User, the market is segmented into Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS), and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cell Counting Market

The growth of the cell counting market is significantly driven by substantial innovations in technology, including the introduction of sophisticated and reliable automated cell counters, cutting-edge flow cytometers, and advanced imaging systems. These developments are fostering increased demand and stimulating market expansion. The heightened efficiency and precision of modern cell counting solutions are also contributing to this growth, as they provide rapid and accurate results alongside comprehensive analyses. Ultimately, these technological advancements play a crucial role in enhancing clinical diagnostics and bolstering research outcomes, thereby further motivating market progression and establishing the importance of effective cell counting methods in various applications.

Restraints in the Cell Counting Market

In certain areas, the limited reimbursement options available for various cell counting systems can pose challenges to their financial viability, hindering the willingness of healthcare providers and researchers to adopt these technologies. This constraint may lead to reduced demand for cell counting systems, ultimately stifling market expansion. Additionally, the absence of adequate reimbursement mechanisms can discourage investment in innovative cell counting technologies, making it difficult for stakeholders to explore or implement these advancements. Consequently, these financial barriers significantly limit the potential growth and overall adoption of cell counting solutions within the healthcare sector.

Market Trends of the Cell Counting Market

The Cell Counting market is experiencing a notable shift towards prioritizing cell functionality and viability alongside traditional cell counting methods. Researchers and clinicians are increasingly recognizing the importance of assessing not just the quantity of cells but also their health and activity, vital for advanced applications in regenerative medicine, drug discovery, and cancer research. This trend is driving the development of innovative technologies tailored for comprehensive evaluations of cell behavior, ultimately yielding deeper insights into cellular mechanisms. As a result, the demand for sophisticated tools and methodologies that enhance understanding of cell viability and function is set to shape the future landscape of this market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Value Chain Analysis
Case Study Analysis

Cell Counting Market by Product

Market Overview
Consumables
- Media, Sera, And Reagents
- Assay Kits
- Microplates
- Accessories
- Other Consumables
Instruments
- Spectrophotometers
- Single-Mode Readers
- Multi-Mode Readers
- Flow Cytometers
- Hematology Analyzers
- Fully Automated Analyzers
- Semi-Automated Hematology Analyzers
- Cell Counters
- Automated Cell Counters
- Hemocytometers/Manual Cell Counters
- Microscopes

Cell Counting Market by Application

Market Overview
Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
Medical Applications
- Noninvasive Prenatal Diagnosis
- In Vitro Fertilization
- Circulating Tumor Cell Detection
Industrial Applications

Cell Counting Market by End User

Market Overview
Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS)
Other End Users

Cell Counting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexcelom Bioscience LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tip Biosystems (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Logos Biosystems, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments